Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Gunnarsson

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.
Plos One|February 9, 2018
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controlsPierre de Flon, Lars Söderström, Katarina Laurell, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2019
High serum concentration of vitamin D may protect against multiple sclerosisMartin Biström, Lucia Alonso-Magdalena, Oluf Andersen, et al.
Acta Neurologica Scandinavica|February 12, 2019
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trialPierre de Flon, Katarina Laurell, Peter Sundström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2020
Leptin levels are associated with multiple sclerosis riskMartin Biström, Johan Hultdin, Oluf Andersen, et al.
Annals of Clinical and Translational Neurology|May 3, 2022
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosisDaniel Jons, Henrik Zetterberg, Martin Biström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2019
Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MSMathias Granqvist, Joachim Burman, Martin Gunnarsson, et al.
Neurology|June 19, 2016
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximabPierre de Flon, Martin Gunnarsson, Katarina Laurell, et al.
Annals of Neurology|February 1, 2011
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabMartin Gunnarsson, Clas Malmeström, Markus Axelsson, et al.
Neurology|October 29, 2017
Monitoring disease activity in multiple sclerosis using serum neurofilament light proteinLenka Novakova, Henrik Zetterberg, Peter Sundström, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 25, 2013
Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosisMarkus Axelsson, Clas Malmeström, Martin Gunnarsson, et al.
Plos One|February 9, 2018
Immunological profile in cerebrospinal fluid of patients with multiple sclerosis after treatment switch to rituximab and compared with healthy controlsPierre de Flon, Lars Söderström, Katarina Laurell, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 17, 2019
High serum concentration of vitamin D may protect against multiple sclerosisMartin Biström, Lucia Alonso-Magdalena, Oluf Andersen, et al.
Acta Neurologica Scandinavica|February 12, 2019
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trialPierre de Flon, Katarina Laurell, Peter Sundström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 8, 2020
Leptin levels are associated with multiple sclerosis riskMartin Biström, Johan Hultdin, Oluf Andersen, et al.
Annals of Clinical and Translational Neurology|May 3, 2022
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosisDaniel Jons, Henrik Zetterberg, Martin Biström, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 9, 2019
Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MSMathias Granqvist, Joachim Burman, Martin Gunnarsson, et al.
Neurology|June 19, 2016
Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximabPierre de Flon, Martin Gunnarsson, Katarina Laurell, et al.
Annals of Neurology|February 1, 2011
Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabMartin Gunnarsson, Clas Malmeström, Markus Axelsson, et al.
Neurology|October 29, 2017
Monitoring disease activity in multiple sclerosis using serum neurofilament light proteinLenka Novakova, Henrik Zetterberg, Peter Sundström, et al.
Pageof 4